Editorial Board

Editors-in-Chief

Professor Giovanni Sotgiu, MD, PhD, FERS, University of Sassari, Italy
Prof Giovanni Sotgiu, MD, PhD, FERS, is full Professor of Medical Statistics – University of Sassari, Italy. He got two medical specializations in Infectious Diseases and in Medical Statistics and a PhD in Methodology of Clinical Trials. He is dean of the Faculty of Medicine and Surgery– University of Sassari, Italy. His research activity is focused on medical statistics, epidemiology and prevention of infectious and non-infectious diseases, hospital and environmental hygiene, health education.


 

Founding Editor
Professor Allan Cripps, Griffith University, Australia (deceased 2022)


Associate Editors
Professor Stuart C Clarke, PhD, FRCPath, FFPH University of Southampton, UK
David Cleary, PhD, University of Birmingham, UK
Professor Keertan Dheda, MBBCh, FCP, FCCP, PhD, FRCP, University of Cape Town, South Africa
Joseph A. Lewnard, PhD, UC Berkeley School of Public Health, USA
Michele Mondoni, MD, University of Milan, Italy
Narcisa Muresu, PhD, University of Sassari, Italy
Stephanie Perniciaro, PhD, MPH, Yale University, USA
Mariangela Valentina Puci, PhD, University of Pavia, Italy
Professor Catherine Satzke, PhD, Murdoch Childrens Research Institute, Australia
Valentijn Schweitzer, PhD, University Medical Center Utrecht, the Netherlands
Katrina Traber, MD, PhD, Boston University School of Medicine, USA


Editorial Board Members

Professor Werner Albrich, MD, Cantonal Hospital St Gallen and University of Basel, Switzerland

Professor Martin Antonio, PhD, London School of Hygiene & Tropical Medicine, UK

Professor Antonio Anzueto, MD, University of Texas Health Science Center, USA

Emma Best, MD, University of Auckland, New Zealand

Professor Debby Bogaert, MD, PhD, University Medical Center Utrecht, Netherlands

Professor Jeremy Brown, PhD, University College London, UK
Jeremy Brown is an academic respiratory consultant with a subspecialty interest in lung infection. Dr Brown did his clinical training in London alternating with Wellcome funded laboratory research at Imperial College into respiratory pathogens. Since 2003 he has run his own laboratory at UCL and been a clinical consultant at UCLH. Dr Brown's laboratory investigates Streptococcus pneumoniae pathogenesis and mechanisms of immunity, as well as assessing new potential vaccine candidates. Important findings made by his laboratory include mechanisms and role during infection of cation acquisition by S. pneumoniae, identification of the first pneumococcal pathogenicity island, the central role of complement system for immunity to S. pneumoniae (including the mechanisms by which the complement system is activated and how these are prevented by the bacteria), and more recently describing the mechanisms of naturally acquired adaptive immunity to S. pneumoniae. Dr Brown's clinical practice

Professor Anne Chang, MD, PhD, MBBS, MPHTM, FRACP, FAPSR, FAHMS, Queensland University of Technology and Menzies School of Health Research, Australia
Professor Anne Chang (MBBS MPHTM FRACP PhD FAPSR FAHMS) is an established clinician researcher recognised for her contributions to clinical research in the areas of paediatric cough, bronchiectasis and evidence based articles. She has helped develop and apply evidence based medicine for respiratory illness in children, in Australia and internationally in the areas of cough, bronchiectasis and asthma. She is the Division Leader of Child Health at the Menzies School of Health Research and leads an Australian National Health and Medical Research Centre of Research Excellence in Indigenous Children’s Lung Health. Her main clinical practice is at the Children’s Hospital in Brisbane. She has been a NHMRC practitioner fellow since 2004 and has published over 400 peer reviewed articles and book chapters. Her major interest are in Indigenous health issues, evidence based management, airway disease, protracted bacterial bronchitis, cough and suppurative lung disease in children.

Professor James Chalmers, MBChB, PhD, FRCPE, FERS, University of Dundee, UK

Attapon Cheepsattayakorn, MD, 10th Zonal Tuberculosis and Chest Diseases Center, Thailand

Catia Cilloniz, PhD, Universidad de Barcelona, Spain

Professor Robert Cohen, MD, Universite Paris Est, France

Professor Ron Dagan, MD, Ben-Gurion University of the Negev, Israel
Ron Dagan is Distinguished Professor of Pediatrics and Infectious Diseases at the Ben-Gurion University of the Negev, Beer-Sheva. He founded the Pediatric Infectious Disease Unit at the Department of Pediatrics, Soroka University Medical Center, Beer-Sheva, Israel, and served as its director from 1987 to June 2014. His previous appointments include Adjunct Associate Professor of Pediatrics at the University of Rochester, New York, USA, from 1993 to 1998, in addition to Advisor for Infectious Diseases at the Israeli Ministry of Health. Professor Dagan obtained his MD degree in 1974 from the Hadassah Medical School of the Hebrew University, Jerusalem, Israel. A member of several national and international advisory committees and medical and scientific associations, Professor Dagan was the Chairman of the Advisory Committee for Infectious Diseases of the Israeli Society of Pediatrics from 1992 to 1997 and has served on the National Advisory Committee on Infectious Diseases and Immunization since 1991. He is also a Founding Member of the World Society of Pediatric Infectious Diseases (WSPID) and a Fellow of the Infectious Diseases Society of America (IDSA). He served as a member of the Executive Committee of the International Society of Infectious Disease (ISID) from 2010 to 2016. Professor Dagan has been involved in the World Health Organization (WHO) Working Group on Pneumococcal Nasopharyngeal Carriage and the WHO Pneumonia Radiology Working Group. He served as President of the European Society for Paediatric Infectious Diseases (ESPID) from 2004 to 2006, as President of the World Society for Pediatric Infectious Diseases (WSPID) from 2006 through 2009 and as Chair of the Board of the International Symposia on Pneumococcus and Pneumococcal Diseases (ISPPD) from 2010 to mid-2016.  

Charles Dela Cruz, MD, PhD, Yale University, USA

Professor Vandana Eshwara, MD, Kasturba Medical College, India

Professor Susanna Esposito, MD, University of Perugia, Italy

Professor Steven Graham, MD, University of Melbourne, Australia

Professor Cameron Grant, MD, PhD, University of Auckland and Starship Children’s Hospital, New Zealand

Shamez Ladhani, Public Health England Colindale, UK

Professor Amanda Leach, PhD, Menzies School of Health Research, Australia

Orin Levine, PhD, Johns Hopkins Bloomberg School of Public Health, USA

Corinne Levy, MD, Universite Paris Est, France

Professor Wei Shen Lim, MD, Nottingham University Hospitals NHS Trust, UK

Grant Austin Mackenzie, PhD, MPH, Basse Field Station, Medical Research Council, Gambia
Dr Mackenzie is an epidemiologist/paediatrician with a particular interest in pneumococcal disease and vaccines, pneumonia and severe bacterial infections. He trained at the Royal Children’s Hospital in Melbourne, Australia. His PhD at Menzies School of Health Research in Darwin described the effectiveness of pneumococcal conjugate vaccine in northern Australia. His MPH studies focussed on Aboriginal health, epidemiology and statistics. He then spent two years with a paediatric HIV programme in Nairobi, Kenya, seconded from the University of Sydney. He has been based at the Medical Research Council (UK) unit in the Gambia since 2008. Dr Mackenzie has been a Clinical Epidemiologist at the Basse Field Station of MRC (UK) The Gambia, since 2008. His research falls under the Disease Control and Elimination Theme. He co-ordinates surveillance for pneumococcal disease and carriage in eastern Gambia, evaluating the effectiveness of the introduction of pneumococcal conjugate vaccine to reduce rates of invasive disease, radiologic pneumonia, carriage, and the cost-effectiveness of vaccination. He is also involved in studies evaluating different pneumococcal vaccine schedules, the aetiology of pneumonia, documenting short and long-term outcomes after childhood pneumonia, socio-economic risk factors for pneumonia, evaluating IMCI criteria for pneumonia, and describing the epidemiology of pneumonia and the causes of serious bacterial illness.

Professor Shabir Ahmed Madhi, MD, PhD, National Institute for Communicable Diseases, South Africa

Professor Keith Meyer, MD, MS, University of Wisconsin School of Medicine and Public Health, Wisconsin, USA
Keith Meyer, MD, MS is a Professor of Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin, USA. Dr. Meyer is a physician-scientist in the Section of Allergy, Pulmonary, Critical Care, and Sleep Medicine Division of the Department of Medicine, and he has served as the Medical Director of Lung Transplantation, Director of the UWHC Interstitial Lung Disease Clinic/Program, and Director of the Adult Cystic Fibrosis Program. Dr. Meyer’s current research interests include pathogenesis and treatment of interstitial lung diseases with an emphasis on idiopathic pulmonary fibrosis, clinical and translational research in lung transplantation, new therapies for cystic fibrosis lung disease, and respiratory infections. Basic science and translational research projects include development of a novel blood test to detect sepsis, protein folding in Alzheimer disease, interactions of phospholipase A2 and different forms of albumin in various disease states, and the relationship of advancing age with immune function and susceptibility to respiratory infections.

Professor Kim Mulholland, MD, Menzies School of Health Research, Australia

Professor David Murdoch, MD, University of Otago, New Zealand

Professor Daniel Musher, MD, Baylor College of Medicine, USA
Dr. Musher graduated Harvard with high honors in history and did his medical training at  Columbia, Bellevue and Tufts-New England Medical Center. He joined the Baylor College of Medicine faculty in 1971 and rapidly rose to the rank of tenured Professor of Medicine and Professor of Molecular Virology and Microbiology. His special areas of interest in medicine are bacterial diseases and pneumonia. He has coauthored more than 500 publications. He loves reading and is an avid string quartet player; he was the founding concertmaster of the Texas Medical Center Orchestra.  He is active in communal organizations, especially in the Jewish and musical communities in Houston

Professor Carlos Javier Orihuela, PhD, University of Texas Health Science Center, USA

Professor William Pomat, PhD, Institute of Medical Research, Papua New Guinea

Professor Jordi Rello, MD, PhD, Vall d'Hebron University Hospital, Spain
Jordi Rello has served as Professor of Medicine at Universitat Autonoma de Barcelona and URV in Tarragona, Spain. He has performed clinical research in the Critical Care Department and is Director of the Clinical Research & Innovation in Pneumonia and Sepsis (CRIPS) Group at Vall d'Hebron Barcelona Campus Hospital: http://www.vhir.org/gr/crips  He earned his Doctor of Medicine with Honors and his PhD on Infectious Diseases at the University of Barcelona, Spain, followed by a residence and fellowship in Critical Care at the Hospital de Sant Pau in Barcelona, Spain. His areas of research include studies on epidemiology of ventilator-associated pneumonia or severe community-acquired pneumonia, treatment of infections in critically ill patients and postoperative management of lung transplant.  Prof Rello has directed 17 doctoral thesis, he has an H-index of 96 (Google Scholar, accessed January 2018). He has chaired different guidelines and Position Papers, such as the ESCMID Guidelines on aerosolized antibiotics in Mechanically Ventilated patients.

Professor Marcos Restrepo, MD, PhD, University of Texas Health Science Center at San Antonio, USA

Professor Ger Rijkers, PhD, University College Roosevelt, The Netherlands 

Jason Rosch, PhD, St Jude Children's Research Hospital, USA

Professor Marco Aurelio Safadi, MD, Santa Casa de Sao Paulo School of Medical Sciences, Brazil

Yuichiro Shindo, MD, PhD, Nagoya University Graduate School of Medicine, Japan

Alistair Standish, PhD, Flinders University, Australia

Motoi Suzuki, National Institute of Infectious Diseases, Japan

Antoni Torres, MD, PhD, University of Barcelona, Spain

Anita Van Den Biggelaar, PhD, Telethon Kids Institute, Australia

Stefan Vestjens, PhD, Diakonessenhuis Utrecht, The Netherlands

Jorge Eugenio Vidal, PhD, University of Mississippi Medical Center, USA

Professor Grant Waterer, MBBS, PhD, University of Western Australia, Australia
Dr Waterer is a respiratory physician at Royal Perth Hospital and is a Professor of Medicine at the University of Western Australia and Professor of Medicine at Northwestern University, Chicago.  He is currently the Chair of the American Thoracic Society and Infectious Diseases Society of America Community Acquired Pneumonia Guidelines having been a panel member of the 2017 ATS/IDSA HAP/VAP guidelines.  He has over 170 peer reviewed publication, more than 60 invited international presentations, is the Section Editor for Infections for the European Respiratory Journal, and is on the Editorial Board of many journals including the American Journal of Respiratory and Critical Care Medicine, Chest and Pneumonia.  In addition to his academic qualifications he has an MBA, is currently a board member of the North Metropolitan Area Health Service and a Medical Director at Royal Perth Hospital.

Daniel Wootton, PhD, University of Liverpool, UK